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Glutamate and taurine are increased in ventricular cerebrospinal
fluid of severely brain-injured patients
Abstract
Glutamate contributes to secondary brain damage, resulting in cell swelling and brain edema. Under in
vitro conditions, increased extracellular levels of the amino acid taurine reflect glutamate-induced
osmotic cell swelling. In vivo, increases in cerebrospinal fluid (CSF) taurine could, therefore, unmask
glutamate-mediated cytotoxic edema formation and possibly differentiate it from vasogenic edema. To
test this hypothesis, ventricular CSF glutamate and taurine levels were measured in 28 severely
brain-injured patients on days 1, 5, and 14 after trauma. Posttraumatic changes in CSF amino acids were
investigated in regard to extent of tissue damage and alterations in brain edema as estimated by
computerized tomography. On day 1, CSF glutamate and taurine levels were significantly increased in
patients with subdural or epidural hematomas (8+/-0.8/71+/-12 microM), contusions (21+/-4.1/122+/-18
microM), and generalized brain edema (13+/-3.2/80+/-15 microM) compared to lumbar control CSF
(1.3+/-0.1/12+/-1 microM; p < 0.001). CSF amino acids, however, did not reflect edema formation and
resolution as estimated by computerized tomography. CSF taurine correlated positively with glutamate,
eventually depicting glutamate-induced cell swelling. However, parallel neuronal release of taurine with
its inhibitory function cannot be excluded. Thus, the sensitivity of taurine in unmasking cytotoxic edema
formation is weakened by the inability in defining its origin and function under the conditions chosen in
the present study. Overall, persisting pathologic ventricular CSF glutamate and taurine levels are highly
suggestive of ongoing glial and neuronal impairment in humans following severe traumatic brain injury.
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JOHN F. STOVER,1 MARIA C. MORGANTI-KOSSMANN,1 PHILIPP M. LENZLINGER,1
RETO STOCKER,1 OLIVER S. KEMPSKI,2 and THOMAS KOSSMANN1
ABSTRACT
Glutamate contributes to secondary brain damage, resulting in cell swelling and brain edema. Un-
der in vitro conditions, increased extracellular levels of the amino acid taurine reflect glutamate-in-
duced osmotic cell swelling. In vivo, increases in cerebrospinal fluid (CSF) taurine could, therefore,
unmask glutamate-mediated cytotoxic edema formation and possibly differentiate it from vasogenic
edema. To test this hypothesis, ventricular CSF glutamate and taurine levels were measured in 28
severely brain-injured patients on days 1, 5, and 14 after trauma. Posttraumatic changes in CSF
amino acids were investigated in regard to extent of tissue damage and alterations in brain edema
as estimated by computerized tomography. On day 1, CSF glutamate and taurine levels were sig-
nificantly increased in patients with subdural or epidural hematomas (8 ± 0.8/71 ±12 /¿M), con-
tusions (21 ± 4.1/122 ± 18 fiM), and generalized brain edema (13 ± 3.2/80 ± 15 fiM) compared to
lumbar control CSF (1.3 ± 0.1/12 ± 1 fiM; p < 0.001). CSF amino acids, however, did not reflect
edema formation and resolution as estimated by computerized tomography. CSF taurine correlated
positively with glutamate, eventually depicting glutamate-induced cell swelling. However, parallel
neuronal release of taurine with its inhibitory function cannot be excluded. Thus, the sensitivity of
taurine in unmasking cytotoxic edema formation is weakened by the inability in defining its origin
and function under the conditions chosen in the present study. Overall, persisting pathologic ven-
tricular CSF glutamate and taurine levels are highly suggestive of ongoing glial and neuronal im-
pairment in humans following severe traumatic brain injury.
Key words: brain edema; cell swelling; cerebrospinal fluid; contusion; glutamate; taurine; traumatic brain
injury
INTRODUCTION tenuated glial uptake and passive translocation from
blood via a damaged blood-brain barrier (Katayama et
Traumatic brain injury is associated with structural, al., 1990; Westergren et al., 1994). A close relationshipfunctional, and metabolic impairment of glial, neu- between the degree of traumatic brain injury and the ex-
ronal and endothelial homeostasis (Mclntosh et al., tent of extracellular glutamate accumulation has been
1996). One of the consequences is an increase in extra- demonstrated in animal (Palmer et al., 1993) and clinical
cellular glutamate due to sustained neuronal release, at- studies (Bullock et al., 1995). The excitatory amino acid
'Department of Trauma Surgery, University Hospital Zürich, Zürich, Switzerland,
institute for Neurosurgical Pathophysiology, Mainz, Germany.
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glutamate is known for its toxic potential and has been
shown to cause glial and neuronal swelling and possibly
cell death (Choi et al., 1987; Schneider et al., 1993). In-
tracellular accumulation of water referred to as cytotoxic
brain edema is attributed to impaired ionic and energetic
homeostasis(Katayamaetal., 1990;Katayamaetal., 1992;
Nilsson et al., 1993; Nilsson et al., 1996) and is believed
to develop sequentially or parallel to vasogenic edema for-
mation. Glutamate-induced cell swelling is linked to com-
pensatory release of the volume-regulatory amino acid tau-
rine (Menéndez et al., 1989; Dutton et al., 1991 ; Saransaari
and Oja, 1991), which could possibly reflect developing
cytotoxic edema formation under in vivo conditions.
In brain-injured patients, posttraumatic recognition of
secondary brain damage in terms of cytotoxic edema for-
mation would allow to counteract and possibly prevent
further cellular perturbation. In clinical routine, however,
computerized tomography (CT) is only of limited value
in unmasking glutamate-induced cell swelling as vaso-
genic and cytotoxic edema formation are not sufficiently
discernible in pericontusional brain structures. Therefore,
analysis of an endogenous substance of cellular origin,
for example, taurine, could theoretically reveal otherwise
occult cell swelling.
Previous studies have shown that analysis of cere-
brospinal fluid (CSF) allows to estimate ongoing patho-
logic changes within cerebral and spinal tissues (Baker
et al., 1993; Shimada et al., 1993; Palmer et al., 1994;
Stover et al., 1997).
Therefore, the aims of the present study were to in-
vestigate changes in ventricular CSF glutamate and tau-
rine levels of head-injured patients in regard to the ex-
tent of structural brain damage and to elucidate if taurine
unmasks progression and resolution of brain edema as
assessed by sequentially performed CT.
MATERIALS AND METHODS
Study Population
Studied patients with isolated brain injury were ad-
mitted with a GCS < 8 to the University Hospital Zürich
within 12 h after trauma. Following CT evaluation the
patients were craniotomized to remove subdural or
epidural hematomas and to implant intraventricular
catheters. These indwelling catheters were inserted
through nontraumatized brain areas. Patients with signif-
icant injuries to the thorax, abdomen, pelvis, or extrem-
ities were excluded. On the intensive care unit (ICU), the
intubated and mechanically ventilated patients were
treated according to a standard protocol (Stocker et al.,
1995), which was not influenced by the present investi-
gations. Parenteral nutrition with amino acid-containing
solutions was not performed in these patients. All patients
received enterai nutrition immediately upon arrival on the
ICU. Neurological outcome of these patients was as-
sessed 6 months after trauma. The study protocol was ap-
proved by the University Hospital Medical Ethics Board.
Evaluation of Brain Damage According to
Computerized Tomography
CT scans were performed upon admission, followed
by control scans on days 1, 5, and 14 after trauma. Ex-
tent of brain damage was assessed by calculating size of
contusions and perifocal edema using the formula for el-
lipsoids [volume = 4/3 ttX a X b X c (cm3)]. General-
ized edema was diagnosed by the absence or compres-
sion of cerebral sulci, ventricles, and basal cisterns
(Weisberg et al., 1990).
CSF Sampling and Control CSF
CSF was collected on ice over 24 h daily until removal
of catheters. Samples were centrifuged at 1,000 revolu-
tions per minute (rpm) for 10 min at 4°C and frozen at
-70°C until further analysis. Control CSF samples were
taken from neurological patients undergoing diagnostic
lumbar puncture. They were free of any pathologic find-
ings as previously described in detail (Stover et al., 1997).
Amino Acid Analysis
Amino acids were analyzed by high-performance liq-
uid chromatography (HPLC) (®Waters Millipore Corp.,
Milford, MA) using orthophthaldialdehyd precolumn de-
rivatization (Fürst et al., 1990). Deproteinized CSF sam-
ples were mixed with potassium carbonate, centrifuged,
and stored at
—
70°C until analysis. Fluorescence detec-
tion was set at 330 nm (excitation) and 450 nm (emis-
sion wave length). Stationary phase was a Spherisorb C-
18 column (125 X 4 mm; 3-/tm particle size). Mobile
phases were (a) stock buffer mixed with 1 % tetrahydro-
furan and 5% acetonitrile (pH 7) and (b) stock buffer-
acetonitrile (50/50; pH 7.2). Stock buffer consisted of
1.724 g/L sodium dihydrogen phosphate and 1.77 g/L
disodium hydrogen phosphate (40/60). After injection, a
stepped gradient at a flow rate of 0.6 ml/min was applied(0-5 min 100% A, 5-52 min 0-95% B, 52-60 min 95-0%
B). A mixture of amino acids was analyzed as external
standards. Sample peak areas were compared to areas of
corresponding standard amino acids of known concen-
tration, which allowed calculation of measured sample
concentration.
Statistical Analysis
Results are presented as mean ± standard error of the
mean (SEM). Investigated parameters were compared for
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Table 1. Epidemiológica!. Data of Investigated Patients
According to the Extent of Structural Brain Damage
SDH/EDH Contusions Generalized edema
Number of patients
Age
Years
Range
Females/males
ICU
Days
Range
Outcome
Dead
Vegetative state
Severe disability
Moderate disability
Good recovery
4/1
36 ± 6
20-46
1/3
21 ± 5
12-31
16
35 ± 4
16-60
4/12
33 ± 3
16-48
4
6
2
43 ± 7
17-67
1/6
23 ± 5
9-36
ICU, intensive care unit; SDH, subdural hematoma; EDH, epidural hematoma.
significant differences within and between patients with
different degrees of structural brain damage assessed by
CT scans using one-way analysis ofvariances (ANOVA),
Kruskal-Wallis, and Dunn's tests or ranked-sum test for
nonparametric data, where appropriate. Correlations of
neurotransmitters were performed by linear regression
analysis. Differences between the groups were rated sig-
nificant at p < 0.05.
RESULTS
Patient Data
A total of 28 brain-injured patients were studied and
grouped according to initial CT findings: five patients
presented with subdural or epidural hematomas only,
while 16 showed contusions, and seven had generalized
brain edema. Age distribution was comparable in all
groups, ranging from 16 to 67 years. The female/male ra-
tio was similar in patients with subdural or epidural
hematomas and contusions, whereas male patients pre-
sented more often with generalized brain edema. Hospi-
talization on the ICU ranged from 9 to 48 days and was
shortest in patients with sole subdural or epidural
hematomas. Neurological outcome for all patients is
shown in Table 1.
Extent of Structural Brain Damage in Patients
Serial CT scans performed in patients with contusions
revealed a significant increase in contusion size and peri-
focal edema during the first 24 h (Table 2). Thereafter,
contusions and perifocal edema showed a tendency to re-
solve. Their calculated sizes, however, remained signif-
icantly increased by day 14 compared to the initial as-
sessment. Performed CT studies in patients with subdural
or epidural hematomas did not show any additional con-
tusions or secondary ischémie damage adjacent to im-
mediately removed hematomas. The degree of general-
ized brain edema resolved during the study period as gyri
and sulci, and the basal cisterns became discernible.
Quantification of generalized brain edema, however, was
not done.
Influence of Brain Damage on CSF Amino Acids
CSF glutamate and taurine levels reflected the extent
of traumatic brain damage (Table 3). They were signifi-
cantly higher compared to control lumbar CSF values
from nontraumatized patients (glutamate/taurine: 1.3 ±
0.1/12 ± 1 pM; p < 0.001). On day 1 after trauma, low-
est values were found in patients with subdural or
epidural hematomas (8 ± 0.8/71 ± 12 pM), while higher
Table 2. Changes in Sizes of Contusions
and Surrounding Edema Formation in
Patients With Cortical Contusions
Day Contusion size (cm3) Perifocal edema (cm3)
0
1
5
14
15 ± 5
51 ± 15 +
48 ± 12+
30 ± 12
50 ± 25
170 ± 28+
190 ± 29+
118 ± 32+
Increases are significant compared to the extent of tissue
damage as seen on the initial CT scans (p < 0.001).
137
STOVER ET AL.
Table 3. Ventricular CSF Glutamate and Taurine Concentrations in Patients
With Different Lesion Types (SDH/EDH, Contusions, and Generalized Edema)
Brain pathology Glutamate (fiM) Taurine (pM) Serine (pM)
Controls (n = 20)
SDH/EDH (n = 5)
Contusion (n = 16)
Generalized edema (n = 7)
Lumbar CSF
Day 1
Day 5
Day 14
Day 1
Day 5
Day 14
Day 1
Day 5
Day 14
1.3
8
14
6
21
16
16
13
12
11
0.1
0.8
1.6*
1.3
4.1+
1.7
2.7+
3.2+
3.0
5.1+
12 ± 1
71 ± 12
82 ± 21
76 ± 9
122 ± 18
116 ± 23
102 ± 19+
80 ± 15
110 ± 39
59 ± 20
45 ± 8
34 ± 6
40 ± 6
30 ± 4
38 ± 8
29 ± 5
30 ± 6
38 ± 6
29 ± 7
26 ± 3
Differences within the groups (*) and compared to corresponding time points of SDH/EDH (+) are significant atp < 0.05.
levels were encountered in patients with contusions(21 ± 4.1/122 ± 18 pM) and generalized brain edema(13 ± 3.2/80 ± 15 pM). Only patients with subdural or
epidural hematomas showed a significant secondary in-
crease in CSF glutamate levels by the fifth posttraumatic
day (14 ± 1.6 pM; p < 0.001) followed by a significant
decrease by day 14 (6 ± 1.3 pM; p < 0.001). CSF tau-
rine, however, did not show similar changes. On day 1,
CSF glutamate and taurine concentrations were signifi-
cantly higher in patients with contusions compared to
those with generalized brain edema (21 ± 4.1/122 ± 18
versus 13 ± 3.2/80 ± 15 pM; p < 0.05) and remained
unchanged thereafter. CSF serine, an amino acid lacking
any transmitter function within the central nervous sys-
tem, remained remarkably stable in all brain-injured pa-
tients. Progression and resolution of brain damage as es-
timated by computerized tomography was not reflected
by CSF amino acids despite a trend to smaller contusions
and resolving perifocal and generalized brain edema by
day 14.
Mutual Dependency Between CSF Glutamate and
Taurine Levels
CSF taurine and glutamate concentrations of the three
selected time points (days 1,5, and 14 after trauma) were
pooled for each group of investigated patients to perform
regression analysis. Correlating CSF taurine with gluta-
mate levels revealed a mutual dependency between these
two amino acids in patients with contusions (taurine =
34.8 + 3.4 X glutamate; n = 48; r = 0.56; p < 0.001)
(Fig. 1A) and generalized brain edema (taurine =
-5.1 + 6.1 X glutamate; n = 21; r = 0.95; p < 0.001)
(Fig. IB). Patients with subdural or epidural hematomas
alone did not reveal a significant correlation.
c
Ü
B
c
3
to
O
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CSF glutamate [uM]
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CSF glutamate [uM]
FIG. 1. (A) Significant correlation between CSF taurine and
glutamate levels in patients with contusions (solid circle; n =
64; r = 0.56; p < 0.001). (B) Significant correlation between
CSF taurine and glutamate levels in patients with generalized
brain edema (open square; n = 32; r = 0.95; p < 0.001).
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DISCUSSION
Bed-side monitoring of pathological changes follow-
ing traumatic brain injury in humans is facilitated by sam-
pling of CSF via intraventricular catheters. In 28 severely
brain-injured patients, ventricular CSF glutamate and tau-
rine levels reflected the extent of structural brain damage
as higher values were measured in patients with contu-
sions and generalized brain edema, while low values were
found in patients with subdural or epidural hematomas.
Sampling of ventricular CSF reflects neurochemical al-
terations within cerebral tissue as increased concentra-
tions are moved passively via bulk flow towards the ven-
tricles (Baker et al., 1993; Shimada et al., 1993; Palmer
et al., 1994). Preserved glial and neuronal uptake mech-
anisms, and mixture with cerebrospinal and extracellular
fluid are believed to dilute and reduce free amino acid
levels measured in the ventricular system. Consequently,
ventricular transmitter concentrations only represent a
small fraction of the actual levels found in the vicinity of
damaged tissue. Emerging experimental and clinical data
underlines the importance of continuously monitoring the
cerebral extracellular space of brain-injured patients
which is best accomplished by microdialysis (Bullock et
al., 1995; Zauner et al., 1996; Landolt and Langemann,
1996). Characterizing interstitial levels of amino acids
with this elegant technique is superior to collecting CSF
via indwelling ventricular catheters as microdialysis al-
lows detection of minute, fast, and topographically lo-
calized changes which are masked by time-consuming
diffusion processes, bulk flow and dilution of CSF within
the ventricular system.
Under physiological conditions transmitters are main-
tained at low levels within the extracellular space due to
neuronal and glial uptake (Danbolt, 1994). Normal ex-
tracellular glutamate and taurine levels are within the
micromolar range while they are stored in millimolar con-
centrations intracellularly (Ottersen, 1988; Storm-
Mathisen et al., 1992). Intact ionic and energetic home-
ostasis is indispensable in preventing uncontrolled
leakage down existing concentration gradients as their
transmitter function is not limited enzymatically within
the synaptic cleft as seen for acetylcholine (Danbolt,
1994).
In traumatic and ischémie brain injury, uncontrollable
release of glutamate (Nilsson et al., 1990; Hagberg et al.,
1985) is attributed to general depolarization and impaired
ionic homeostasis (Katayama et al., 1990; Katayama et
al., 1992; Nilsson et al., 1993, 1996), inhibition of up-
take by arachidonic acid and free oxygen radicals
(Volterra et al., 1994), and reversal of the energy-depen-
dent glutamate transporter due to ionic and energetic im-
pairment (Madl and Burgesser, 1993). Primary brain in-
jury is complicated by local ischemia known to occur in
the presence of contusions and subdural hematoma (Bul-
lock et al., 1991; Muizelaar and Schröder, 1994;
Kochanek et al., 1995) despite successful maintenance of
global cerebral perfusion pressure. Posttraumatic isch-
émie tissue damage, in turn, is associated with sustained
release of glutamate (Bullock et al., 1991). This could
possibly explain persisting pathologic CSF values in all
patients and the secondary increase in CSF glutamate
seen by the fifth posttraumatic day in patients with sub-
dural hematomas.
Observed progression of brain edema during the first
2 posttraumatic days is in accordance with experimental
findings (Eriskat et al., 1994; Kochanek et al., 1995). En-
largement of perifocal edema is related to evolving va-
sogenic and cytotoxic edema which seems to persist up
to 14 days after trauma. The excitotoxin glutamate is
widely accepted to contribute to these pathologic alter-
ations. According to in vivo and in vitro studies gluta-
mate damages the blood-brain barrier (Zuccarelo and An-
dersen, 1993; Mayhan and Didion, 1996) and causes
cellular swelling (van Harreveld and Fifkova, 1971;
Schneider et al., 1993).
Artificial increases in CSF amino acid levels due to
blood-brain barrier damage as seen in animal studies
(Kempski et al., 1990; Koizumi et al., 1997) cannot be
excluded in the present study. These artificial increases,
however, seem subordinate since CSF serine levels re-
main rather stable in all investigated patients. General-
ized edema formation is seen as the radiological corre-
late to cytotoxic edema (Weisberg et al., 1990) and thus
should not be associated with a damaged blood-brain bar-
rier. Therefore, pathologic CSF glutamate and taurine
levels in patients with hemispheric edema underline the
assumption that alterations in ventricular CSF transmit-
ters reflect glial and neuronal impairment and are not in-
creased due to passive translocation via a damaged blood-
brain barrier.
Significantly increased ventricular CSF concentrations
of the amino acid taurine and the positive correlation with
glutamate in the investigated brain-injured patients sug-
gest a mutual dependency between these two amino acids.
Among other functions, taurine is known to regulate cell
volume as it is released nonvesicularly. As taurine leaves
swollen cells it shifts ions and water for stochiometrical
reasons from the intracellular to the extracellular com-
partment restoring initial cell volume (Pasantes-Morales
et al., 1990). There is substantial evidence that glutamate
induces osmotic cell swelling as ionic homeostasis is dis-
turbed and Na+ accumulates intracellularly (Barbour et
al., 1988; Kimelberg et al., 1989; Schneider et al., 1993).
Glutamate-mediated increase in cell volume, in turn, has
been shown to result in an increased release of taurine
139
STOVER ET AL.
(Saransaari and Oja, 1991). Thus, the positive correlation
between taurine and glutamate in the investigated patients
could reflect underlying cytotoxic edema formation.
Apart from osmoregulation, taurine is also known to ex-
ert neuromodulating (Kuriyama, 1980) and inhibitory
functions (Okamoto et al., 1983; Taber et al., 1986). Neu-
ronal excitation results in a sustained release of taurine
(Magnusson et al., 1991) regulating exocytosis of exci-
tatory amino acids with the aim of balancing glutamate-
mediated excitotoxicity (Kamisaki et al., 1993). Co-re-
lease of these two amino acid transmitters is seen in the
fact that changes in extracellular taurine levels occur in
conjunction with alterations of free glutamate concentra-
tions in traumatic and ischémie injuries (Nilsson et al.,
1990; Hagberg et al., 1985) and has also been demon-
strated in cultured neurons and astrocytes (Holopainen et
al., 1989). Therefore, observed parallel increases in CSF
taurine and glutamate levels in brain-injured patients do
not allow to differentiate cytotoxic from physiologic ef-
fects, as they most likely occur at the same time. Conse-
quently, analysis of taurine in ventricular CSF as col-
lected over 24 h in brain-injured patients is only of
subordinate value in possibly unmasking developing and
resolving cytotoxic edema.
Progression and resolution of pericontusional and gen-
eralized brain edema as estimated by computerized to-
mography is not reflected by changes in rather stable CSF
amino acids despite a trend to lower values by the end
of the study period. Therefore, it is impossible to define
if pathologic CSF values precede, follow or occur in con-junction with radiological findings. This is best explained
by the multitude of interacting uptake and release mech-
anisms in damaged and surrounding tissue.
The present investigation revealed ventricular CSF
glutamate and taurine levels to remain pathologically el-
evated up to and including day 14 after trauma in se-
verely brain-injured patients. These findings are highly
suggestive of persisting glial and neuronal impairment
with a preserved risk of secondary brain damage in terms
of neurotoxic cell damage lasting at least two weeks af-
ter the traumatic insult.
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